Agnès Veyradier

Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies

Marie Scully, Spero R. Cataland, Paul Coppo et al. · Journal of Thrombosis and Haemostasis · 2016 · 484 citations · Full text

Thrombopoiesis, Thrombosis, Venous Thrombosis +8

Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience

Paul Coppo, Michaël Schwarzinger, M. Buffet et al. · PLoS ONE · 2010 · 407 citations · Full text

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

Antoine Froissart, M. Buffet, Agnès Veyradier et al. · Critical Care Medicine · 2011 · 286 citations

Redefining outcomes in immune TTP: an international working group consensus report

Adam Cuker, Spero R. Cataland, Paul Coppo et al. · Blood · 2021 · 197 citations · Full text

A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP

Paul Coppo, Michaël Bubenheim, Élie Azoulay et al. · Blood · 2020 · 175 citations · Full text